Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart C Gordon

Showing results (91-100 of 214) with videos related to

Pageof 22
Sort By:
The American Journal of Managed Care|June 3, 2014
Hepatitis B virus infection testing and prevalence among Asian and Pacific IslandersVinutha Vijayadeva, Phillip R Spradling, Anne C Moorman, et al.
Antiviral Therapy|September 13, 2005
A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis CJohn G McHutchison, Mitchell L Shiffman, Ramsey C Cheung, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 30, 2002
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infectionStephen Pianko, John G McHutchison, Stuart C Gordon, et al.
Gastroenterology|October 22, 2013
Hepatitis C screening: summary of recommendations from the clinical decision tool, Mark D Boldt, Joel V Brill, et al.
Journal of Gastroenterology and Hepatology|June 24, 2025
Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary CholangitisAllyce Caines, Mei Lu, Trueman Wu, et al.
Journal of Gastroenterology and Hepatology|April 20, 2026
Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis"Allyce Caines, Mei Lu, Trueman Wu, et al.
Gastroenterology|August 10, 2004
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environmentCarlo Selmi, Marlyn J Mayo, Nancy Bach, et al.
The American Journal of Managed Care|August 17, 2019
Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunitiesAnne C Moorman, Jian Xing, Loralee B Rupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2021
The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011-2017Philip R Spradling, Yuna Zhong, Anne C Moorman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2026
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBCHumberto C Gonzalez, Stuart C Gordon, Sheri Trudeau, et al.
Pageof 22

Showing results (91-100 of 214) with videos related to

Sort By:
Pageof 22
The American Journal of Managed Care|June 3, 2014
Hepatitis B virus infection testing and prevalence among Asian and Pacific IslandersVinutha Vijayadeva, Phillip R Spradling, Anne C Moorman, et al.
Antiviral Therapy|September 13, 2005
A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis CJohn G McHutchison, Mitchell L Shiffman, Ramsey C Cheung, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 30, 2002
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infectionStephen Pianko, John G McHutchison, Stuart C Gordon, et al.
Gastroenterology|October 22, 2013
Hepatitis C screening: summary of recommendations from the clinical decision tool, Mark D Boldt, Joel V Brill, et al.
Journal of Gastroenterology and Hepatology|June 24, 2025
Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary CholangitisAllyce Caines, Mei Lu, Trueman Wu, et al.
Journal of Gastroenterology and Hepatology|April 20, 2026
Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis"Allyce Caines, Mei Lu, Trueman Wu, et al.
Gastroenterology|August 10, 2004
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environmentCarlo Selmi, Marlyn J Mayo, Nancy Bach, et al.
The American Journal of Managed Care|August 17, 2019
Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunitiesAnne C Moorman, Jian Xing, Loralee B Rupp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2021
The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011-2017Philip R Spradling, Yuna Zhong, Anne C Moorman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2026
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBCHumberto C Gonzalez, Stuart C Gordon, Sheri Trudeau, et al.
Pageof 22